Assenagon Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.6M Sell
947,495
-332,699
-26% -$21.3M 0.07% 204
2026
Q1
$89.8M Buy
1,280,194
+152,464
+14% +$10.7M 0.14% 130
2025
Q4
$92.3M Sell
1,127,730
-120,224
-10% -$8.98M 0.13% 132
2025
Q3
$74.2M Buy
1,247,954
+250,367
+25% +$12.3M 0.1% 167
2025
Q2
$40.4M Sell
997,587
-127,718
-11% -$5.75M 0.06% 244
2025
Q1
$57.8M Sell
1,125,305
-21,507
-2% -$1.06M 0.1% 185
2024
Q4
$63.5M Buy
1,146,812
+5,565
+0.5% +$253K 0.1% 169
2024
Q3
$37.5M Buy
1,141,247
+77,825
+7% +$2.19M 0.07% 216
2024
Q2
$28.9M Buy
+1,063,422
New +$35.8M 0.06% 223
2023
Q3
Sell
-146,194
Closed -$2.64M 1469
2023
Q2
$2.64M Hold
146,194
0.01% 672
2023
Q1
$1.84M Sell
146,194
-37,014
-20% -$541K 0.01% 864
2022
Q4
$2.69M Sell
183,208
-19,217
-9% -$318K 0.01% 713
2022
Q3
$3.47M Sell
202,425
-159,316
-44% -$2.53M 0.01% 564
2022
Q2
$5.28M Buy
+361,741
New +$5.43M 0.02% 528

Other funds holding TARS